Ontology highlight
ABSTRACT:
SUBMITTER: Lamoth F
PROVIDER: S-EPMC4879309 | biostudies-literature | 2016 Jun
REPOSITORIES: biostudies-literature
Lamoth Frédéric F Damonti Lauro L Alexander Barbara D BD
Journal of clinical microbiology 20160323 6
No clinical breakpoints are available to delineate antifungal drug efficacy in non-Aspergillus invasive mold infections (NAIMIs). In this analysis of 39 NAIMI episodes, the MIC of the first-line antifungal drug was the most important predictor of therapeutic response. For amphotericin B, an MIC of ≤0.5 μg/ml was significantly associated with better 6-week outcomes. ...[more]